199 related articles for article (PubMed ID: 22021535)
21. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
[TBL] [Abstract][Full Text] [Related]
22. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
23. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
24. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
Kubota Y; Kamei S; Nakano M; Ehara H; Deguchi T; Tanaka O
Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
[TBL] [Abstract][Full Text] [Related]
25. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
[TBL] [Abstract][Full Text] [Related]
26. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
[TBL] [Abstract][Full Text] [Related]
27. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer.
Salami SS; Vira MA; Turkbey B; Fakhoury M; Yaskiv O; Villani R; Ben-Levi E; Rastinehad AR
Cancer; 2014 Sep; 120(18):2876-82. PubMed ID: 24917122
[TBL] [Abstract][Full Text] [Related]
29. Comparison of re-biopsy with preceded MRI and re-biopsy without preceded MRI in patients with previous negative biopsy and persistently high PSA.
Park BK; Jeon SS; Park B; Park JJ; Kim CK; Lee HM; Choi HY
Abdom Imaging; 2015 Mar; 40(3):571-7. PubMed ID: 25367810
[TBL] [Abstract][Full Text] [Related]
30. [Prostate cancer detection by prostate biopsy among Japanese with prostate-specific antigen below 4.0 ng/ml].
Kanno T; Shibasaki N; Tsuji Y; Taki Y; Takeuchi H
Hinyokika Kiyo; 2006 Mar; 52(3):181-4. PubMed ID: 16617870
[TBL] [Abstract][Full Text] [Related]
31. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance.
Quentin M; Blondin D; Klasen J; Schek J; Buchbender C; Miese FR; Antoch G; Barski D; Albers P; Arsov C
Urol Int; 2012; 89(1):25-9. PubMed ID: 22677880
[TBL] [Abstract][Full Text] [Related]
34. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.
Haffner J; Lemaitre L; Puech P; Haber GP; Leroy X; Jones JS; Villers A
BJU Int; 2011 Oct; 108(8 Pt 2):E171-8. PubMed ID: 21426475
[TBL] [Abstract][Full Text] [Related]
35. Increasing prostate-specific antigen levels differently influence prostate cancer detection rates of two different 12-core prostate biopsy schemes.
Lodeta B; Benko G; Trkulja V
Urol Int; 2013; 91(1):75-80. PubMed ID: 23614932
[TBL] [Abstract][Full Text] [Related]
36. [Value of real-time elastography to guide the systematic prostate biopsy in men with normal digital rectal exam].
Brock M; Eggert T; Löppenberg B; Braun K; Roghmann F; Palisaar RJ; Noldus J; von Bodman C
Aktuelle Urol; 2013 Jan; 44(1):40-4. PubMed ID: 23325671
[TBL] [Abstract][Full Text] [Related]
37. Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy.
Jambor I; Kähkönen E; Taimen P; Merisaari H; Saunavaara J; Alanen K; Obsitnik B; Minn H; Lehotska V; Aronen HJ
J Magn Reson Imaging; 2015 May; 41(5):1394-404. PubMed ID: 24956412
[TBL] [Abstract][Full Text] [Related]
38. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305
[TBL] [Abstract][Full Text] [Related]
39. Is it effective to perform two more prostate biopsies according to prostate-specific antigen level and prostate volume in detecting prostate cancer? Prospective study of 10-core and 12-core prostate biopsy.
Yoon BI; Shin TS; Cho HJ; Hong SH; Lee JY; Hwang TK; Kim SW
Urol J; 2012; 9(2):491-7. PubMed ID: 22641493
[TBL] [Abstract][Full Text] [Related]
40. MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
Schimmöller L; Blondin D; Arsov C; Rabenalt R; Albers P; Antoch G; Quentin M
AJR Am J Roentgenol; 2016 Jan; 206(1):92-9. PubMed ID: 26700339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
